Chemical Compound

2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CV 3146; CVT 3146; Lexiscan; NQZ-021; Rapiscan; 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide

CAS Registry Number 313348-27-5
2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CV 3146; CVT 3146; Lexiscan; NQZ-021; Rapiscan; 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide 结构式
Primary record

2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CV 3146; CVT 3146; Lexiscan; NQZ-021; Rapiscan; 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide

库存
2,192 克
纯度
99.4 %
CAS
313348-27-5

化合物标识与属性

CAS
313348-27-5
PubChem CID
219024
SMILES
CNC(=O)C1=CN(N=C1)C2=NC(=C3C(=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)N
Canonical SMILES
CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1

名称与同义词

  • Regadenoson
  • Lexiscan
  • Rapiscan
  • 313348-27-5
  • Regadenoson anhydrous
  • regadenosonum
  • Lexiscan (TN)
  • Regadenoson (INN)
  • CVT-3146
  • Regadenoson monohydrate
  • Regadenoson (Standard)
  • Regadenoson [USAN:INN]
  • Regadenoson Impurity 18
  • REGADENOSON [MI]
  • RefChem:426699
  • 7AXV542LZ4
  • REGADENOSON [INN]
  • UNII-7AXV542LZ4
  • DTXSID4057712
  • D0XE1C
  • Regadenoson; CVT-3146
  • CVT 3146
  • AC1Q5LB1
  • CHEMBL317052
  • REGADENOSON [MART.]
  • DTXCID5031501
  • SCHEMBL678893
  • 2XLN4Y044H
  • AC1L55X1
  • C15H18N8O5
  • GTPL5596
  • orb1305186
  • SCHEMBL29462353
  • CTK4G6871
  • HY-A0168R
  • AOB6869
  • C01EB21
  • CVT3146
  • CHEBI:135613
  • LEXISCAN(R) (REGADENOSON)
  • LZPZPHGJDAGEJZ-AKAIJSEGSA-N
  • MFCD09832544
  • GLXC-05958
  • HMS3886O21
  • AMY27715
  • EX-A2148
  • HY-A0168
  • Tox21_113668
  • AR-1D6945
  • BDBM50119132
  • CID219024
  • EBC-26913
  • s5358
  • ZINC13818943
  • AKOS026750593
  • C15-H18-N8-O5
  • AN-1022
  • CCG-268525
  • CS-5612
  • CV-3146
  • DB06213
  • NR07283
  • 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine
  • NCGC00249892-01
  • AC-35838
  • AS-56292
  • AT-36942
  • BP-58629
  • 2-[4-(methylcarbamoyl)-1h-pyrazol-1-yl]adenosine
  • LS-193008
  • B5904
  • CAS-313348-27-5
  • CVT-3146;CVT3146;CVT 3146
  • J1.806.399I
  • D12568
  • 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
  • Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-
  • 348R275
  • A848906
  • EN300-19633972
  • 2-[4-(Methylcarbamoyl)-1H-pyrazole-1-yl]adenosine
  • Q7307897
  • Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-
  • 2-[4-(Methylaminocarbonyl)-1H-pyrazole-1-yl]adenosine
  • N-Methyl-1-(adenosine-2-yl)-1H-pyrazole-4-carboxamide
  • 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine
  • Adenosine,2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-
  • B0084-107114
  • (1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide
  • 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide
  • 1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide
  • 1-(6-Amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
  • 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-2-yl]-N-methyl-pyrazole-4-carboxamide
  • 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CVT 3146; Lexiscan; Regadenoson
  • (1-{9-[(4s,2r,3r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-n-methylcarboxamide
  • 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
  • 1-[6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-2-yl]-1H-pyrazole-4-carboxylic acid methylamide
  • 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide<br/>CVT 3146<br/>CVT-3146<br/>CVT3146<br/>Lexiscan<br/>regadenoson
  • 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CV 3146; CVT 3146; Lexiscan; NQZ-021; Rapiscan; 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide
  • 36186-55-7
  • 6-Amino-2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]purine-9-yl-beta-D-ribofuranoside;1-(6-amino-9-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yloxy)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide